The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders

The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders

Neurodevelopmental and late-onset neurodegenerative disorders present as separate entities that are clinically and neuropathologically quite distinct. However, recent evidence has highlighted surprising commonalities and converging features at the clinical, genomic, and molecular level between these...

Full description

Bibliographic Details
Main Authors:	C. Alejandra Morato Torres, Zinah Wassouf, Faria Zafar, Danuta Sastre, Tiago Fleming Outeiro, Birgitt Schüle
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	International Journal of Molecular Sciences
Subjects:	alpha-synuclein <i>SNCA</i> <i>PARK2</i> 22q11.2 deletion syndrome autism spectrum disorders Parkinson’s disease
Online Access:	https://www.mdpi.com/1422-0067/21/16/5724

Similar Items

Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease
by: Desiree A. Piper, et al.
Published: (2018-04-01)

Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation
by: Katharina Pieger, et al.
Published: (2022-08-01)

Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson’s Patient-Derived Neuronal Cells
by: Lukas Seebauer, et al.
Published: (2022-02-01)

Consequences of 22q11.2 Microdeletion on the Genome, Individual and Population Levels
by: Małgorzata Karbarz
Published: (2020-08-01)

DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson’s Individuals with <i>GBA1</i> Mutations
by: Adam R. Smith, et al.
Published: (2023-01-01)

Fluorescence in situ hybridization (FISH) screening for the 22q11.2 deletion in patients with clinical features of velocardiofacial syndrome but without cardiac anomalies
by: Paula Sandrin-Garcia, et al.
Published: (2007-01-01)

Chromosome 22q11.2 deletion causes PERK-dependent vulnerability in dopaminergic neurons
by: Yuko Arioka, et al.
Published: (2021-01-01)

Interaction between Parkin and <i>α</i>-Synuclein in <i>PARK2</i>-Mediated Parkinson’s Disease
by: Daniel Aghaie Madsen, et al.
Published: (2021-01-01)

Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol
by: Sarah Threlfell, et al.
Published: (2021-04-01)

Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes
by: Yihang Han, et al.
Published: (2022-06-01)

Hypoparathyroidism concomitant with macrothrombocytopenia in an elderly woman with 22q11.2 deletion syndrome
by: Hsiu-Chien Yang, et al.
Published: (2018-10-01)

Palatoschisis, Schizophrenia and Hypocalcaemia: Phenotypic Expression of 22q11.2 Deletion Syndrome (DiGeorge Syndrome) in an Adult
by: Melissa Elise van der Meijs, et al.
Published: (2021-04-01)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
by: Angeliki Spathopoulou, et al.
Published: (2022-01-01)

Language Profiles of School-Aged Children with 22q11.2 Copy Number Variants
by: Jente Verbesselt, et al.
Published: (2023-03-01)

Variants in <i>KMT2A</i> in Three Individuals with Previous Suspicion of 22q11.2 Deletion Syndrome
by: Henrique Garcia Silveira, et al.
Published: (2024-02-01)

Genetic Elements at the Alpha-Synuclein Locus
by: Jordan Prahl, et al.
Published: (2022-07-01)

Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms
by: Nicholas A Donnelly, et al.
Published: (2022-08-01)

Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s disease
by: Faria Zafar, et al.
Published: (2022-04-01)

The 15q11.2 BP1-BP2 Microdeletion (<i>Burnside–Butler</i>) Syndrome: In Silico Analyses of the Four Coding Genes Reveal Functional Associations with Neurodevelopmental Disorders
by: Syed K. Rafi, et al.
Published: (2020-05-01)

Genotypic and phenotypic variability of 22q11.2 microdeletions – an institutional experience
by: Gabrielle C. Manno, et al.
Published: (2021-12-01)

Recurrent convulsions, hypocalcemia, and hypoparathyroidism related to delayed diagnosis of 22q11.2 deletion syndrome in a middle‐aged man
by: Tomoya Okazaki, et al.
Published: (2016-10-01)

Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
by: Enquan Xu, et al.
Published: (2022-01-01)

Neurodevelopmental dimensional assessment of young children at high genomic risk of neuropsychiatric conditions
by: Samuel J. R. A. Chawner, et al.
Published: (2023-06-01)

The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
by: Couch Yvonne, et al.
Published: (2011-11-01)

Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
by: Alix Booms, et al.
Published: (2021-10-01)

Parent-Reported Social-Communicative Skills of Children with 22q11.2 Copy Number Variants and Siblings
by: Jente Verbesselt, et al.
Published: (2022-10-01)

The Unique Experience of a New Multidisciplinary Program for 22q Deletion and Duplication Syndromes in a Community Hospital in Florida: A Reaffirmation That Multidisciplinary Care Is Essential for Best Outcomes in These Patients
by: Zaimary Meneses, et al.
Published: (2022-10-01)

Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency. Two years’ experience in Catalonia (Spain)
by: Andrea Martin‐Nalda, et al.
Published: (2019-12-01)

Prenatal diagnosis of 22q11.2 deletion syndrome associated with right aortic arch, left ductus arteriosus, cardiomegaly, and pericardial effusion
by: Yen-Ni Chen, et al.
Published: (2016-02-01)

Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature
by: Anastasia Bougea
Published: (2023-03-01)

Mechanisms of Neurodegeneration in Various Forms of Parkinsonism—Similarities and Differences
by: Dariusz Koziorowski, et al.
Published: (2021-03-01)

Screening Method for 22q11 Deletion Syndrome Involving the Use of TaqMan qPCR for <i>TBX1</i> in Patients with Conotruncal Congenital Heart Disease
by: Felix-Julian Campos-Garcia, et al.
Published: (2022-08-01)

Smith-Magenis Syndrome—Clinical Review, Biological Background and Related Disorders
by: Berardo Rinaldi, et al.
Published: (2022-02-01)

Contribution of Mitochondrial DNA Heteroplasmy to the Congenital Cardiac and Palatal Phenotypic Variability in Maternally Transmitted 22q11.2 Deletion Syndrome
by: Boris Rebolledo-Jaramillo, et al.
Published: (2021-01-01)

The 22q11.2 Low Copy Repeats
by: Lisanne Vervoort, et al.
Published: (2022-11-01)

A Case of Bernard-Soulier Syndrome Associated with 22q11.2 Deletion Syndrome
by: Oh Cheol Kwon, et al.
Published: (2023-10-01)

Relationship between high trait anxiety in 22q11.2 deletion syndrome and the difficulties in medical, welfare, and educational services
by: Naomi Nakajima, et al.
Published: (2023-03-01)

A case study of the utilization of clozapine treatment for treatment‐resistant schizophrenia associated with 22q11.2 deletion syndrome
by: Arisa Tsurue, et al.
Published: (2023-06-01)

The genetic landscape of polymicrogyria
by: Jesmy James, et al.
Published: (2022-01-01)

Prenatal diagnosis and molecular cytogenetic characterization of chromosome 22q11.2 deletion syndrome associated with congenital heart defects
by: Yu-Ling Kuo, et al.
Published: (2014-06-01)